Patricia S. Andrews - 12 Feb 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Role: Director
Signature: /s/ Kirk Look, Attorney-in-Fact
Issuer symbol: ONCY
Transactions as of: 12 Feb 2026
Net transactions value: +$30,292
Form type: 4
Filing time: 13 Feb 2026, 07:00:21 UTC
Previous filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Andrews Patricia S	Director	C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO	/s/ Kirk Look, Attorney-in-Fact	13 Feb 2026	0001445710

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONCY	Common Shares	Purchase	$30,292	+35,400	+83%	$0.8557	78,128	12 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8483 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8483 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.